Literature DB >> 17354003

[Laboratory diagnostics for systemic sclerosis].

R Mierau1, A Roers, E Genth.   

Abstract

For systemic sclerosis, laboratory tests can play a supplementary role to clinical investigations, imaging techniques and functional tests. Typical autoantibodies support early diagnosis and help in assigning patients to subgroups of the disease; negative results for antinuclear antibodies suggest exclusion of the diagnosis. To detect organ involvement and comorbidity, the laboratory contributes by clinical chemistry, in certain cases by histopathological findings and by the cytological assessment of broncho-alveolar lavage fluid. Inflammatory parameters are of minor importance. Multiple autoantibody determinations in the course of the disease are not yet helpful. Numerous additional laboratory parameters are of value for investigating pathogenesis, but have not yet been generally introduced into the routine diagnostics of systemic sclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17354003     DOI: 10.1007/s00393-007-0156-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  47 in total

1.  Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Authors:  Anna Fijalkowska; Marcin Kurzyna; Adam Torbicki; Grzegorz Szewczyk; Michal Florczyk; Piotr Pruszczyk; Monika Szturmowicz
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

2.  Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

Authors:  C Rubens; R Ewert; M Halank; R Wensel; H D Orzechowski; H P Schultheiss; G Hoeffken
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

3.  Sjögren's syndrome in progressive systemic sclerosis.

Authors:  A A Drosos; A P Andonopoulos; J S Costopoulos; E D Stavropoulos; C S Papadimitriou; H M Moutsopoulos
Journal:  J Rheumatol       Date:  1988-06       Impact factor: 4.666

4.  Type III collagen aminopropeptide levels in serum of patients with progressive systemic scleroderma.

Authors:  T Krieg; I Langer; H Gerstmeier; J Keller; H Mensing; G Goerz; R Timpl
Journal:  J Invest Dermatol       Date:  1986-12       Impact factor: 8.551

5.  A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.

Authors:  Michele Mondini; Matteo Vidali; Marco De Andrea; Barbara Azzimonti; Paolo Airò; Roberta D'Ambrosio; Piersandro Riboldi; Pier Luigi Meroni; Emanuele Albano; Yehuda Shoenfeld; Marisa Gariglio; Santo Landolfo
Journal:  Arthritis Rheum       Date:  2006-12

6.  Clinical and serological heterogeneity in patients with anticentromere antibodies.

Authors:  Shoji Miyawaki; Hiroko Asanuma; Susumu Nishiyama; Yasuhiko Yoshinaga
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

Review 7.  Serological assessment of type I collagen burden in scleroderma spectrum disorders: a systematic review.

Authors:  M Dziadzio; R E Smith; D J Abraham; R J Stratton; A Gabrielli; C M Black; C P Denton
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

8.  Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis.

Authors:  T A Osial; T L Whiteside; R B Buckingham; G Singh; E L Barnes; J M Pierce; G P Rodnan
Journal:  Arthritis Rheum       Date:  1983-04

9.  Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in scleroderma.

Authors:  M R Patrick; B W Kirkham; M Graham; L C Harrision
Journal:  J Rheumatol       Date:  1995-04       Impact factor: 4.666

10.  Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.

Authors:  Michael Mahler; Reinout Raijmakers; Cornelia Dähnrich; Martin Blüthner; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2005-04-01       Impact factor: 5.156

View more
  1 in total

1.  [Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)].

Authors:  N Hunzelmann; E Genth; T Krieg; M Meurer; I Melchers; P Moinzadeh; C Pfeiffer; G Riemekasten; E Schulze-Lohoff; C Sunderkoetter; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.